Srinivasan Yegnasubramanian

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Clear cell renal cell carcinoma consensus transcriptomic programs reveal converging trajectories towards aggressive disease

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-06-26

• Structural and cellular insights into DCTPP1 antagonists and their synergistic action with DNMT inhibitors

  Proceedings of the National Academy of Sciences · 2026-06-15

• Somatic mutations reveal hyperactive Notch signaling in prurigo nodularis

  JCI Insight · 2026-04-21

• Abstract 1981: Absence of somatic copy number alterations in non-neoplastic prostate epithelium.

  Cancer Research · 2026-04-03

• Molecular Monitoring of Neurologic Injury during Intramedullary Spinal Cord Tumor Surgery: A Case Report

  Journal of Neuro-Oncology Discovery · 2026-03-19

• 448 Adding ERG to Combined Basal Cell and AMACR Staining Increases Diagnostic Accuracy for Prostate Carcinoma

  Laboratory Investigation · 2026-03-01

• RRM1 inhibition sensitizes lung adenocarcinoma to decitabine treatment

  Cell Death and Disease · 2026-02-26

• Supplementary Figure 3 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

  2026-01-02

• Supplementary Figure 5 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

  2026-01-02

• Supplementary Table 2 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

  2026-01-02

• Supplementary Table 3 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

  2026-01-02

• Supplementary Table 1 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

  2026-01-02

• Supplementary Figure 2 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

  2026-01-02

• Supplementary Figure 4 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

  2026-01-02

• Supplementary Figure 6 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

  2026-01-02

• Supplementary Table 5 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

  2026-01-02

• Data from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

  2026-01-02

• Supplementary Table 4 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

  2026-01-02

• Supplementary Figure 7 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

  2026-01-02

• Supplementary Figure 1 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

  2026-01-02